NCT04083716View on ClinicalTrials.gov

A Study to Assess the Relative Bioavailability and Food Effect of ABI-H2158 in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 6, 2019

Primary Completion Date

October 5, 2019

Study Completion Date

October 7, 2019

Conditions
Chronic Hepatitis B
Interventions
DRUG

ABI-H2158 Reference Formulation

ABI-H2158 tablets Reference Formulation

DRUG

ABI-H2158 Test Formulation

ABI-H2158 tablets Test Formulation

Trial Locations (1)

85283

Celerion, Tempe

Sponsors
All Listed Sponsors
lead

Assembly Biosciences

INDUSTRY

NCT04083716 - A Study to Assess the Relative Bioavailability and Food Effect of ABI-H2158 in Healthy Adults | Biotech Hunter | Biotech Hunter